Consonance Capital Management LP Heron Therapeutics, Inc. Transaction History
Consonance Capital Management LP
- $7.28 Million
- Q3 2022
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
191Shares Held
123MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$32.3 Million1.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$10.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$10.1 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.6MShares$9.2 Million0.05% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$8.45 Million58.47% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $144M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...